Drug intelligence / Profile preview

piperlonguminine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Piperlonguminine is a natural alkaloid found in various Piper species, including *Piper longum*, *Piper nigrum*, *Piper chaba*, *Piper wallichii*, and *Piper colubrinum*. It has demonstrated a wide range of biological activities, such as anti-tumor, anti-hyperlipidemic, anti-renal fibrotic, anti-inflammatory, anticancer, antioxidant, antidiabetic, neuroprotective, anti-arthritic, and antiviral properties. Its mechanisms of action involve the inhibition of Transient Receptor Potential Cation Channel Subfamily C Member 6 (TRPC6), suppression of the Toll-like Receptor 4 (TLR4)/Nuclear Factor Kappa B (NF-κB) signaling pathway, and interactions with various proteins including Cyclooxygenase-2 (COX-2), Vascular Endothelial Growth Factor Receptor 2 (VEGFR2), Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta (IKK beta), and SARS-CoV-2 viral proteins (Mpro and Spike protein). It also modulates key cellular pathways involved in cancer and inflammation, such as those mediated by SRC, MTOR, EZH2, and MAPK3, and inhibits several cytochrome P450 enzymes.

02

Targets

TXNRD2 (Thioredoxin reductase 2)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)NF-κBTLR4 (Toll-like receptor 4)XPO1 (Exportin-1)

Beyond the preview

Go deeper on piperlonguminine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on piperlonguminine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call